ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $273,791,000 | -42.3% | 5,122,375 | +22.0% | 2.89% | -26.5% |
| Q4 2015 | $474,307,000 | -2.6% | 4,198,520 | +1.5% | 3.93% | -12.6% |
| Q3 2015 | $486,779,000 | +73.4% | 4,135,412 | +14.1% | 4.50% | +82.7% |
| Q2 2015 | $280,722,000 | +15.4% | 3,625,498 | -13.8% | 2.46% | +21.7% |
| Q1 2015 | $243,242,000 | +79.4% | 4,204,702 | 0.0% | 2.02% | +46.2% |
| Q4 2014 | $135,602,000 | +31.8% | 4,204,702 | 0.0% | 1.38% | +6.8% |
| Q3 2014 | $102,889,000 | +78.7% | 4,204,702 | +29.5% | 1.30% | +83.8% |
| Q2 2014 | $57,588,000 | -7.0% | 3,248,043 | +4.9% | 0.70% | -10.4% |
| Q1 2014 | $61,937,000 | +47.6% | 3,095,318 | +23.8% | 0.79% | +33.2% |
| Q4 2013 | $41,950,000 | – | 2,500,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |